pain management olivier cuignet, md (responsible) gregory minguet, md jan muller, md kirsten...
TRANSCRIPT
![Page 1: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/1.jpg)
Pain ManagementPain Management
Olivier Cuignet, MD (responsible)Gregory Minguet, MD
Jan Muller, MDKirsten Colpaert, MD
![Page 2: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/2.jpg)
pre-hospital care (su)fenta or piritramide iv
Treat as fast and as strong as possible to avoid mechanisms to be discussed
What kind of Burn patients ?
Opioids and FLUID CREEPBurns 2004; 30(6):583-90.
![Page 3: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/3.jpg)
Pre-hospital care of burn patient
(su)fenta or piritramide iv(su)fenta or piritramide iv
Treat as fast and as strong as possible to Treat as fast and as strong as possible to avoid mechanisms to be discussedavoid mechanisms to be discussed
Opioids and FLUID CREEPLocal cooling and water gel
Treat the pain fast and strong with the minimum opioids needed :
« Cocktail de Djibouti » (Ketamine / Bzd / Atropine iv)
What kind of Burn patients ?
![Page 4: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/4.jpg)
Aims Aims
Pain characteristics and analgesics
Lessons learned from our 6 years experience
New approach of burn pain nociceptive hyperalgesia
opioid-induced hyperalgesia
New strategy based on a new pain assessment
![Page 5: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/5.jpg)
Pain CharacteristicsPain Characteristicsdressing changes, post-operative periods, physiotherapynursing care
Procedural Pain (PP): repetitivefrequentexcrutiating
Burn
Background Pain (BgP): constant breakthrough painexcruciating soundeasily defined diffuseresponds well to therapeutics increased therapeutic needs
Wind-ups: Complicated Pain (CP)
![Page 6: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/6.jpg)
Pain control strategy : WHO Scale
Pain control strategy : WHO Scale
STEP 1 : Paracetamol ?
NSAID (Taradyl/Brufen) “10 mg”
STEP 2 : Tramadol 10 mg
Codeine 6.6 mg
STEP 3 : Piritramide 1.25 mg
Hydromorphone 0.134 mg
Morphine 1 mg
Sufentanyl 0.001 mg
![Page 7: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/7.jpg)
Lessons learned from 6 years of Pain Management...
Lessons learned from 6 years of Pain Management...
Pain assessment is mandatory to meet patient’s need.
Appropriate Burn Pain therapy requires huge doses of morphine equivalent
![Page 8: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/8.jpg)
Huge doses Opioids : burns are very painful
burn pain is a long-term process
burn pain is more and more painful
opioid become less efficient over time
Burn Pain therapyBurn Pain therapy
![Page 9: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/9.jpg)
Background PainBackground Pain
Huge doses morphine-equivalent:Intensive Care : iv 100 à 168 mg/24h (sufenta) + bath
Medium Care : oral 65 à 200 mg /24h (tramadol + MSDirect +/- hydromorphone)
Potential problems:Fluid creep Burns 2004; 30(6):583-90.
Immunological Am J Ther 2004; 11(5):354-65.
Endocrine J Clin Endocrinol Metab 2000; 85(6):2215-22.
Tolerance Anasthesiol Intensivmed 2003; 38(1):14-26.
Hyperalgesia J Neurobiol 2004; 6(1):126-48.
![Page 10: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/10.jpg)
Background PainBackground Pain
How to reduce high doses of morphine-equivalent?
Avoid the early hyperalgesia due to
burn and its inflammatory response
Avoid opioid tolerance / opioid hyperalgesiaby limiting the initial opioid doses
New comprehensive physio-pathology
of burn pain
![Page 11: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/11.jpg)
Physio-pathology of burn pain.Physio-pathology of burn pain.
Three periods of Hyperalgesia:Activation (receptors recruitment)Modulation (NMDA, receptors
phosphorylation)Modification (new genes, apoptosis)
Three levels of Burn-induced Hyperalgesia:Peripheral (receptors/ nerves ending)Spinal (dorsal horn)Supra-spinal (brainstem, thalamus, cortex)
time
Non reversibility
![Page 12: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/12.jpg)
Modified from O.H Wilder Smith. Anesthesiology 104, 2006; 601-7
Burn
![Page 13: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/13.jpg)
Treat the pain as soon as possible(before activation of pain amplification mechanisms)
Treat the pain as completely as possibleat the periphery
at the spinal level
at the supra-spinal level
Physio-pathology of burn pain.Physio-pathology of burn pain.
![Page 14: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/14.jpg)
Treat the pain as soon as possible(before pain amplification mechanisms activated)
Treat the pain as completely as possibleat the periphery
at the spinal levelat the supra-spinal level
Treat the pain with as few opioids as possibleto avoid opioid-induced hyperalgesia
to avoid opioid-tolerance
Physio-pathology of burn pain.Physio-pathology of burn pain.
![Page 15: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/15.jpg)
Physio-pathology of burn pain.Physio-pathology of burn pain.
Modified from O.H Wilder Smith. Anesthesiology 104, 2006; 601-7
![Page 16: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/16.jpg)
Pain Control StrategyPain Control Strategy
Peripheral hyperalgesiaHydro-colloids dressing, homografts, antiseptic ointments. Early excisionLoco-regional anesthesia
![Page 17: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/17.jpg)
Procedural Pain: post-operativeProcedural Pain: post-operative
Post-operative:loco-regional anesthesia for donor sites
long-term opioid-sparing effects J Burn Care Rehabil. 2005 Sep-Oct;26(5):409-15
0
1
2
3
4
5
6
7
8
9
10
VA
S s
core
(Dyn
amic
)
6 h 24 h 48 h 72 h 1st Dressing change
controlblockcatheter
0
20
40
60
80
100
120
6 h 24 h 48 h 72 h
control
block
catheter
Post-operative time
Cum
ulat
ive
mor
phin
e (m
g)
![Page 18: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/18.jpg)
Pain Control StrategyPain Control Strategy
Peripheral hyperalgesiaHydro-colloids dressing, homografts, antiseptic ointments. Early excisionLoco-regional anesthesia
Spinal and supraspinal hyperalgesiaAnti-hyperalgesic drugs : kétamine, lidocaine, pregabalinOpioid-sparing agent : clonidine
![Page 19: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/19.jpg)
Pain Control StrategyPain Control Strategy
0
500
1000
1500
2000
2500
3000
Tre
atm
en
t Da
y 1
Tre
atm
en
t Da
y 2
Tre
atm
en
t Da
y 3
Tre
atm
en
t Da
y 4
Tre
atm
en
t Da
y 5
Tre
atm
en
t Da
y 6
Tre
atm
en
t Da
y 7
Tre
atm
en
t Da
y 8
Tre
atm
en
t Da
y 9
Tre
atm
en
t Da
y 1
0
Tre
atm
en
t Da
y 1
1
Tre
atm
en
t Da
y 1
2
Tre
atm
en
t Da
y 1
3
Tre
atm
en
t Da
y 1
4
Tre
atm
en
t Da
y 1
5
Tre
atm
en
t Da
y16
Tre
atm
en
t Da
y 1
7
Tre
atm
en
t Da
y 1
8
Tre
atm
en
t Da
y 1
9
Tre
atm
en
t Da
y 2
0
Tre
atm
en
t Da
y 2
1
ControlGabapentin
Cu
mu
lativ
e M
orp
hin
e c
on
sum
ptio
n (
mg
)
p < 0.05
0
500
1000
1500
2000
2500
3000
Po
stT
r D
ay
1
Po
stT
rDa
y 2
Po
stT
r D
ay
3
Po
stT
r D
ay
4
Po
stT
r D
ay
5
Po
stT
rDa
y 6
Po
stT
r D
ay
7
Po
stT
r D
ay
8
Po
stT
r D
ay
9
Po
stT
r D
ay
10
Po
stT
r D
ay
11
Po
stT
rDa
y 1
2
Po
stT
r D
ay
13
Po
stT
r D
ay
14
Po
stT
r D
ay
15
Po
stT
r D
ay1
6
Po
stT
r D
ay
17
Po
stT
r D
ay
18
Po
stT
r D
ay
19
Po
stT
r D
ay
20
Po
stT
r D
ay
21
ControlGabapentin
Cu
mu
lativ
e M
orp
hin
e c
on
sum
ptio
n (
mg
)
p < 0.05
Gabapentin reduces opioid-consumption during and up to 3 weeks after its administrationBurns. 2007 Feb;33(1):81-6
![Page 20: Pain Management Olivier Cuignet, MD (responsible) Gregory Minguet, MD Jan Muller, MD Kirsten Colpaert, MD](https://reader035.vdocuments.mx/reader035/viewer/2022062407/56649c995503460f949550f5/html5/thumbnails/20.jpg)
Pain Control StrategyPain Control Strategy
Peripheral hyperalgesiaHydro-colloids dressing, homografts, antiseptic ointments. Early excisionLoco-regional anesthesia
Spinal and supraspinal hyperalgesiaAnti-hyperalgesic drugs : kétamine, lidocaine, pregabalinOpioid-sparing agent : clonidine
Opioid-induced hyperalgesiaAssessment of hyperalgesia Judicious use of antihyperalgesic drugs (ketamine, lidocaine, pregabalin)Loco-regional anesthesia
To do